Global Recombinant DNA Technology Market 2021: Share, Trends, Industry Analysis & Forecast 2026
According to the latest report by IMARC Group, titled “Recombinant DNA Technology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the market to grow at a CAGR of XX% during 2021-2026.
The introduction of recombinant DNA technology, or genetic engineering, involves altering genetic material outside an organism and obtaining enhanced and desired characteristics in living organisms. It includes the insertion of DNA fragments from several sources with a desirable gene sequence through an appropriate vector. Besides this, recombinant DNA technology aids in the safe, affordable, and sufficient production of vital proteins needed for dietary purposes and fighting health problems. Consequently, it has multidisciplinary applications and a remarkable potential to improve health, food resources, resistance to divergent adverse environmental effects, etc.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Global
Recombinant DNA Technology Market Trends:
Recombinant DNA technology is being increasingly utilized for treating
different health conditions, primarily by developing new vaccines and pharma
products. This, along with the improving treatment strategies due to the
developing diagnostics kits, monitoring devices, new therapeutic approaches,
etc., are among the significant factors fueling the market. Moreover, the
rising number of research activities conducted on genetically modified
organisms (GMO), which include microorganisms considered as bio degraders and
clean fuel producers, is also propelling the market for recombinant DNA
technology. Additionally, the escalating integration of recombinant DNA
technology with effective gene therapy for replacing defective genes with
normal ones is further anticipated to stimulate the market growth in the coming
years.
Request Free Sample Report: https://www.imarcgroup.com/recombinant-dna-technology-market/requestsample
Global
Recombinant DNA Technology Market 2021-2026 Analysis and
Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report
with the detailed profiles of the key players operating in the market.
Amgen Inc, Cibus, F.Hoffmann-La Roche Ltd, GenScript, GlaxoSmithKline
plc., Horizon Discovery Group plc, Merck KGaA, New England Biolabs, Novo
Nordisk A/S, Pfizer Inc., Sanofi S.A and Syngene International Ltd (Biocon
Limited).
The report has segmented the market on the basis on region, disc type,
material type and end user.
Breakup by Product:
- Medical
o Therapeutic
Agent
o Human
Protein
o Vaccines
- Non-Medical
o Biotech
Crops
o Specialty
Chemicals
o Others
Breakup by Component:
- Expression
System
- Cloning
Vector
Breakup by Application:
- Food
and Agriculture
- Health
and Disease
- Environment
- Others
Breakup by End User:
·
Biotechnology and Pharmaceutical Companies
·
Academic and Government Research Institutes
·
Others
Breakup by Region:
- North
America
- United
States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South
Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United
Kingdom
- Italy
- Spain
- Russia
- Others
- Latin
America
- Brazil
- Mexico
- Others
- Middle
East and Africa
Ask Analyst for Customization and Explore Full Report with TOC &
List of Figure: https://www.imarcgroup.com/recombinant-dna-technology-market
Key highlights of the report:
- Market
Performance (2015-2020)
- Market
Outlook (2021-2026)
- Porter’s
Five Forces Analysis
- Market
Drivers and Success Factors
- SWOT
Analysis
- Value
Chain
- Comprehensive
Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope
of the report, we can provide it to you as a part of the customization.
If you want latest primary and secondary data (2021-2026) with Cost
Module, Business Strategy, Distribution Channel, etc. Click request free sample
report, published report will be delivered to you in PDF format via email
within 24 to 48 hours of receiving full payment.
About Us
IMARC Group is a leading market research company that offers management
strategy and market research worldwide. We partner with clients in all sectors
and regions to identify their highest-value opportunities, address their most
critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic
and technological developments for business leaders in pharmaceutical,
industrial, and high technology organizations. Market forecasts and industry
analysis for biotechnology, advanced materials, pharmaceuticals, food and
beverage, travel and tourism, nanotechnology and novel processing methods are
at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia:
+91-120-433-0800, +91-120-433-0800
Comments
Post a Comment